Preservation of Beta-cell Function in Type 2 Diabetes Mellitus
Status:
Completed
Trial end date:
2011-12-01
Target enrollment:
Participant gender:
Summary
The study evaluates the rate beta-cell function decline in newly diagnosed type 2 diabetic
patients on two different treatment regimens: insulin and metformin versus glyburide,
metformin and pioglitazone.